Clinical Trial Update: Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating intracoronary prourokinase effects on coronary flow during primary PCI in acute myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• ProUrokinase (pro-urokinase)

Snippet

Sponsor: Fudan University | Conditions: Myocardial Infarction, Percutaneous Coronary Intervention | Phase 4 | Status: COMPLETED